{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T04:31:31Z","timestamp":1718512291630},"reference-count":6,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.lungcan.2013.11.018","type":"journal-article","created":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T18:30:15Z","timestamp":1385922615000},"page":"300-301","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Temsirolimus therapy in a patient with lung adenocarcinoma harboring an FBXW7 mutation"],"prefix":"10.1016","volume":"83","author":[{"given":"Liza C.","family":"Villaruz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Socinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2013.11.018_bib0005","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrclinonc.2011.126","article-title":"Personalized medicine in lung cancer: what we need to know","volume":"8","author":"Mok","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.lungcan.2013.11.018_bib0010","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2013.31.15_suppl.8019","article-title":"A multicenter effort to identify driver mutations and employ targeted therapy in patients with lung adenocarcinomas: the Lung Cancer Mutation Consortium (LCMC)","volume":"31","author":"Johnson","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2013.11.018_bib0015","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nature03155","article-title":"Fbxw7\/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene","volume":"432","author":"Mao","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.lungcan.2013.11.018_bib0020","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1126\/science.1162981","article-title":"FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression","volume":"321","author":"Mao","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.lungcan.2013.11.018_bib0025","doi-asserted-by":"crossref","first-page":"9006","DOI":"10.1158\/0008-5472.CAN-07-1320","article-title":"FBXW7\/hCDC4 is a general tumor suppressor in human cancer","volume":"67","author":"Akhoondi","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2013.11.018_bib0030","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/02841860500400979","article-title":"Somatic mutation of hCDC4 gene is rare in lung adenocarcinomas","volume":"45","author":"Woo Lee","year":"2006","journal-title":"Acta Oncol"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500213005321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500213005321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T04:10:01Z","timestamp":1597119001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500213005321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":6,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0169500213005321"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2013.11.018","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Temsirolimus therapy in a patient with lung adenocarcinoma harboring an FBXW7 mutation","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2013.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}